chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient signed up for a Pfizer Covid-19 Vaccination on 07/03/21. On the consent form, the patient indicated that she did not receive any previous dosage of a COVID-19 Vaccine. Patient was administered a first dose of a Pfizer vaccine thereafter. Upon processing the vaccine to the patient's insurance, the claim was rejected due to a DUR duplication error, indicating that the patient had received a COVID 19 vaccine at another location on 04/09/21. After looking in the State vaccine registry, it was listed that the patient had the Janssen COVID 19 Vaccine at Pharmacy on 04/09/21. I called Pharmacy to confirm and it was on their records for this patient.
Within roughly 30 minutes after the shot the left side of my face was numb/tingling I just felt odd  My arm was sore but for a week and a half I couldnt think straight I shouldnt have been driving. The day after the shot I was on my way home from getting taxes done I turned into the median on a route home I take EVERY DAY! When i had to stop at the red light i was way out in the road it was like nothing mattered it was like oh well... maybe a car wont hit me AND NOW MONTHS LATER I ACHE ALL OVER!! My joints all hurt I DID NOT HAVE THIS PRIOR TO THIS DARN SHOT! Someone should be liable This is wrong !
Body Temperature increased, Bloody discharge, Irritable Flushing. Initial information was received from a health care professional in the USA on 25 July 2008.
Patient is describing difficulty with range of motion of left arm and experiences pain that radiates when lifting There is also sensitivity/pain at the site of injection  Patient was given booster dose on 11/20/21, but there was a needle/syringe malfunction where the full dose was not administered - most of the vaccine had spilled from the syringe during administration. Patient was then given another dose to ensure that she had gotten the entire recommended dosage for the booster. After receiving the doses patient described above reactions.
Adverse reactions included pallor in face and lips, clammy and pulse of 64. Patient was laid down on exam table and elevated HOB up. Ice pack was placed on back of neck. Fruit snacks and water were given to patient. After 30 minutes, patient walked to family vehicle under their own power, escorted by nurse, pallor gone, pulse was 76. Patient declared "feeling better."
Vomiting, diarrhea, temp to 102, sweats and chills, muscular aches and pains, shallow breathing, inability to leave my bed 4 days after the first and 3 days after the second.
t104 during noc of 13-went into ER 11AM; t101.6 mild swelling, mod tenderness, no streaking lt deltoid;
After the first dose, my arm was sore.  But after the second dose, the chills began around 3:30 a.m.  Then with the fatigue that I felt, I couldn't convince myself to get out of bed for another blanket.  A severe Headache came next.  I forced myself out of bed at 12:30 pm, only to end up on the couch, after a few sips of water (trying to keep myself hydrated) with a slightly nauseaed stomach.  I returned back to bed 2 hours later, as it was too bright in that room.   Saturday morning I had a commitment and forced myself out of bed and showered.  I still  had a slight headache but then my hips ACHED.  (Not certain if that is from the vaccine or from laying in bed.)  Fatigue was still prevalent on Saturday.   It's now Sunday and most of the side effects have subsided.  Hopefully, a Sunday afternoon nap will help!
Covid monitoring documentation. PT admitted 01/13/22 documented to have positive covid. PT received Moderna 2/9/21 Lot 031AM20A for dose 1. Dose 2 was Moderna given on 3/9/21 Lot 012A21A. PT received Moderna Booster on 11/9/21 Lot 022C21A. PT expired on 1/16/22 due to acute hypoxic respiratory failure secondary to COVID according to the death summary.
Patient had a "psychiatric seizure" apparently has a history of these. Became agitated and aggressive.  911 was called and medics took the staff member to the hospital.
My period was delayed by 4 days. The first day of my menses was normal. Halfway through the second day, I experienced near-hemorrhagic bleeding -- soaking two Super Plus tampons in an hour when I usually don't need to change my tampon more than every 4-6 hours. When I changed my tampon, I encountered large (the length of my hand from fingertips to wrists) blood clots unlike any I had ever seen before, including following labor and delivery (8 years ago). I called my provider who said I should report to the ER if the bleeding continued at that rate. Fortunately, it stopped shortly thereafter.
Received varivax at health dept on 10/10/00. Broke out with varicella rash on 7/28/01. Seen in ER and dx'd as varicella (for another reason).
This case was reported by a physician via sales rep and described the occurrence of syncope in a 11-year-old male patient who received BOOSTRIX (batch number EC9A9, expiry date unknown). Co-suspect products included ENGERIX B pediatric (batch number 73X43, expiry date unknown) and MENVEO (batch number M16003, expiry date unknown). On 16th August 2016, the patient received BOOSTRIX, the 3rd dose of ENGERIX B pediatric and MENVEO. On an unknown date, the dose was an unknown dose. On an unknown date, several minutes after receiving BOOSTRIX, ENGERIX B pediatric and MENVEO, the patient experienced syncope (serious criteria hospitalization), breathing arrested (serious criteria hospitalization and GSK medically significant) and respiration abnormal (serious criteria hospitalization). On an unknown date, the outcome of the syncope, breathing arrested and respiration abnormal were unknown. It was unknown if the reporter considered the syncope, breathing arrested and respiration abnormal to be related to BOOSTRIX, ENGERIX B pediatric and MENVEO. Additional details were provided as follows: The adverse events were reported by a GSK sales representative. The GSK sales representative did not provide patient's date of birth or expiry dates for vaccines. The healthcare professional would like to be contacted. The reported lot number (EC949) for BOOSTRIX did not exist and was updated to EC9A9, according to sales data sheet.
The wife of the pt reported that "he felt knot in arm at injection site and that arm, between elbow and shoulder, became sore and painful on evening of same day and has continued to very gradually get worse. Arm is also getting weaker and he is now unable to raise elbow over shoulder height because of pain and weakness."
Admission 11/16/21; admitted to the hospital with afib, copd, and hypertension; pt recently dx w/COVID;  pt treated for afib with RVR with Cardizem drip and heparin drip; pt became more lethargic and unresponsive; pt depressed after passing of wife and stopped taking all medications, not eating or drinking fluids. Family requested hospice care and was discharge to swing bed and started on comfort measures. pt tested positive for COVID outside facility on 11/09/2021; pt found unresponsive on the morning of 11/17/2021 by nurse.
7/19/08 ER visit for red swollen arm.  Dx with cellulitis and admitted to hospital for abx therapy.  8/11/2008 MR received for DOS 7/19-22/2008 with D/C DX: Cellulitis most likely possible immune reaction to Pneumovax. Pt presented to ER following a syncopal episode with fever, chills and injection site pain, erythema, induration. Pt had felt nauseous and gone to sink to vomit but passed out onto the floor where pt was found. In ER pt had fever of 102.6'F, exam WNL except for injection site cellutis.  Admitted for abx, IVF and telemetry with good resolution of sx.
Sent by PCP for concerns for sepsis/bacterial pneumonia. Recent covid infection approx. 2.5 weeks prior to admission on 2/7. Transferred to ICU on 2/14 due to increasing O2 requirements. Hematology consulted due to her hx of anemia and patient was intermittently transfused. Infectious disease was consulted due to worsening respiratoty status and fevers. Antibiotics were broadened to zyvox, meropenem and cresemba. Required intubation on 2/16 and covid tested +. WBC continued to be high and started on high dose steroids. Patient continued to worsen with max ventialtory support and decreasing renal function. Family requested comfort care.
Patient reported redness, swelling, tenderness and warm to the touch on 8/1/16. Vaccine administered 7/26/16. Patient was told to contact physician to schedule appointment. Patient stated physician determined allergic reaction. Use BENADRYL for the treatment necessary.
Arm sore and swollen at injection site, severe fatigue, chills, body aches, dizziness, brain fog, nausea
Received 0.5ml of Fluzone from multidose vial containing preservative Thimerosal. Mother had requested the single-unit dose without Thimerosal. No clinical adverse event.  1/25/08 There was no adverse event from the vaccine.  Mother is concerned that the THIMOROSAL preservative may eventually cause a problem.
Service member received Anthrax #1 on 08 Jan 03 and one month later developed a rash on bilateral elbows, knees, between fingers, and in the genital area.  This was initially diagnosed as contact dermatitis.  When it started recurring in the same areas, he was diagnosed with eczema/atopic dermatitis. Rx:  Kenalog creme  Continues to have monthly recurrences.    Denies any similar occurrences prior to receipt of Anthrax.
I received the vaccine at 4:20 PM on Friday (3/12).  I had no adverse effects until after I fell asleep.  I woke up at 2:00 AM with a fever, body aches, headache, and severe nausea.  I proceeded to vomit until 6:00 AM.  The following day (3/13) included mild headache, mild body aches, and slight nausea.  By Sunday (3/14), all negative symptoms had gone away.
This spontaneous report was received from a medical assistant and refers to a multiple unspecified patients of unknown age and gender. The patients' concurrent conditions and medical histories were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored (Merck) VARIVAX lot # L019126, expiration date: 27-MAY-2017; lot # K005429, expiration date: 15-APR-2016; lot # K026387, expiration date: 15-DEC-2016; L019126, expiration date: 27-MAY-2017 or ZOSTAVAX lot # L012039, expiration date: 07-JUL-2016; lot # L000448, expiration date: 08-MAR-2016 (exact doses, routes of administration and anatomical locations were not reported). There were no concomitant medications provided. There were no adverse effects reported. Administered doses of vaccines experienced the temperature excursion of 25 degrees Fahrenheit for 15 hours and 20 minutes. There was no previous temperature excursion. Additional information has been requested.
About 3 days after injection, there was a painful, red/purple splotch about 3 inches below the injection site on my right arm. It was only painful when touched, and it was not hard or inflamed.  It had an irregular shape (not circular or with clear edges). It covered 2-3 square inches of skin. It resolved on its own after a couple of days. (The injection site itself was no longer painful at this time).
Information has been received from a female physician assistant (age not reported) who on an unspecified date was vaccinated with 1 dose of 0.5 ML of Gardasil (yeast) (Lot#653978/0955F). The physician assistant reported that after she was injected with Gardasil (yeast) she felt numbness from the injection site progress all the way to her fingers. Unspecified medical attention was sought. At the time of this report, the physician assistant had recovered from the event (date unknown). Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/14/2006.  Initial and follow-up information has been received from a white, 26 year old female, physician assistant whose reported weight was 130 pounds and whose reported height was 67 inches, with no pre-existing allergies or illness who on 01-NOV-2006 was vaccinated intramuscularly (IM) into the left deltoid muscle with the first dose of 0.5 mL dose of GADASIL (Lot # 653978/0955F).  The physician assistant reported she felt numbness and tingling down through her left arm and into her hand as GARDASIL vaccine was administered.  It was reported that there were no long term effects, all signs and symptoms resolved in a few minutes.  Unspecified medical attention was sought.  At the time of this report, the physician assistant had recovered.  Additional information has been requested.
This spontaneous report was received from a medical assistant who was referring to a patient of unknown age gender. There was no information regarding the patient's medical history, concomitant medications, drug reactions or allergies provided. On 20-JUL-2017, the patient was vaccinated with improperly stored ROTATEQ lot # M017558, expiration date: 27-FEB-2017 and with improperly stored PEDVAXHIB lot #L051122, expiration date: 12-OCT-2017 or lot# M045206, expiration date: 27-JUN-2017 (lot number was not specified) both for prophylaxis. The vaccines were stored in temperature 67.5 F for 9 hours and 6 minutes. There was a previous temperature excursion when the vaccines were stored in 72.1F for 3 hours and 58 minutes. The call was because of digital data logger. No adverse effects were reported. Additional information has been requested.
reacted to the Covid vaccine; received Flu and Meningitis vaccines prior to reported event; Initial information received from  on 03-Nov-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 45 year old male patient who reacted to the covid vaccine; received flu and meningitis vaccines prior to reported event while receiving vaccines COVID-19 VACCINE, INFLUENZA VACCINE and MENINGOCOCCAL VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect MENINGOCOCCAL VACCINE for Immunization and INFLUENZA VACCINE for Prophylaxis produced by unknown manufacturer (lot number, dose, formulation, expiry date and strength not reported) via unknown route in unknown administration site.  On an unknown date, the patient received suspect COVID-19 VACCINE not produced by Sanofi Pasteur (lot number, dose, formulation, expiry date and strength not reported) via unknown route in unknown administration site.  On an unknown date the patient reacted to the covid vaccine; received flu and meningitis vaccines prior to reported event (adverse drug reaction) (unknown latency) following the administration of MENINGOCOCCAL VACCINE, INFLUENZA VACCINE and COVID-19 VACCINE.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event. ; Sender's Comments:  01351636:
Got a positive test for COVID-19; Got a positive test for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Got a positive test for COVID-19". The patient had her two primary doses of the Pfizer Biontech COVID-19 vaccine and was now (as of 04Jan2022) overdue for her booster shot. Last Sunday (on an unspecified date) she got a positive test for COVID-19. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. The lot number for bnt162b2 was not provided and will be requested during follow-up.
sick; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (sick) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) had resolved.            Patient took usual medication that patient was taking for years. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Apr-2022: Follow-up received contains no new information
Cellulitis at the injection site that occurred 1 day after the injection was given. Mom proceeded to the ED on Sunday 4/8/18 due to guarding of the left leg and redness at the injection site but denied warmth to touch. He was treated with topical lidocaine and aN I&D was performed. Patient was started on SEPTRA antibiotics as well as topical Mupirocin. Follow up today in clinic with PCP he is showing much improvement.
Had severe case of chicken pox with secondary cellulitis 3 yr following the vax (vaccine failure)
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
an oily, anal discharge that looks orange in the toilet bowl, and bright yellow on toilet paper; This is a spontaneous report from a contactable consumer (patient).  This 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on unknown date at a single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After vaccination, in the evening, the patient has had an oily, anal discharge that looks orange in the toilet bowl, and bright yellow on toilet paper. The patient also stated she must wear a pad, as the discharge is persistent, and happens even when she is not having a bowel movement. The outcome of the event was unknown.  Information about Lot/batch number has been requested.
t104.5 unable to get down 24NOV02 talked w/mom doing better temp down;
A report has been received from a Health Professional concerning a Child, subject of unknown gender, who received FLUMIST quadrivalent (intranasal), 0.2 Millilitres, Once/Single administration. FLUMIST quadrivalent (intranasal) started on an unknown date. The patient experienced itchy/rashy. The outcome of the event of itchy/rashy is unknown. The report was considered to be non-serious.
Covid like symptoms; nausea; chills; fever; headache; body ache; loss of taste; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 38-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 16Apr2021 10:30 (at the age of 38-year-old) at dose 1, single for covid-19 immunisation. Medical history included covid-19 (if covid prior Vaccination: Yes). Patient had Known allergies with Codeine. Patient did not have other vaccine in four weeks, other medications in two weeks. Concomitant medications were not reported. On 16Apr2021 22:30 the patient experienced Covid like symptoms including nausea, chills, fever, headache, chills, body ache and loss of taste. The patient underwent lab tests and procedures which included Nasal Swab (Covid test type post vaccination), SARS covid 19 (Covid test name post vaccination): negative on 16Apr2021. It was unknown whether the patient received treatment for the adverse events. Outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt. got FLUZONE shot, walked to front of store, turned green and fainted. We laid him down, elevated his feet. After 25 minutes, he felt fine and walked out.
Deltoid went necrotic after getting the dose at the site; This spontaneous report was received from a nurse prescriber regarding a 15 year old female patient. Patient's concurrent condition, medical history and concomitant medication were not reported. On an unknown date, the patient was vaccinated with 2nd dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) in the deltoid (dose, strength, lot/batch and expiry: unknown) for prophylaxis. It was reported that, on an unknown date, deltoid went necrotic after getting the dose at the site (injection site necrosis). Treatment was received for the event. Patient sought medical attention. There was no adverse effect with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). Cancer was not involved. The outcome of injection site necrosis was recovering. Causality of the event with respect to suspect therapy was unknown.  Upon internal review, the event injection site necrosis was determined to be medically significant.
Flushing of face. Redness and warmth of injection site and top of opposite shoulder with 5 red macules. Started receding within 20 minutes, almost resolved at 30 minutes.
Hives began appearing on 1/27 beginning on right hand, over course of a week to, both arms from hands to shoulders.  right eyelid, bottom lip, minor individual spots on belly, hip and neck.  generally itchy face and ears.  Use of topical benedryl only through day 8 (today), sought treatment of healthcare provider, then when hives suspected tied to vaccination, reported to Occ Health at employer, recommended by Occupational Health to add Benedryl by mouth.
h/a 29AUG, 30AUG & 31AUG;also took a nap each day;
Tinnitus, constant high pitched tone, worsening over the two months.  Tinnitus noted after 2nd dose of vaccine but it decreased over time to the point of rarely being noticed
Received Shingles vaccine on 12/02/2013. Symptoms began to be noticed on 12/04/2013, including headache, faster pulse rate, some hoarseness & wheezing, numbness & tingling 'pins & needles' feeling on right side of head/scalp/neck. Was sent to E.R. on 12/10/2013 to 'rule out' a stroke. CT was negative, and was given Rx for Prednisone steroid.... Am still experiencing the RSD-CRPS pain at this time.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On an unknown date, the patient was vaccinated with VARIVAX (Merck). Other suspect therapies included PROQUAD (Merck) and ZOSTAVAX. On an unknown date, temperature excursion to ZOSTAVAX, VARIVAX (Merck) and PROQUAD (Merck) which was supported and no product was administered. However, the healthcare worker then stated that the freezer has had episodes of cycling after which the practice had administered all three products. ZOSTAVAX, VARIVAX (Merck) and PROQUAD (Merck) all supported post cycling events described. The healthcare worker had no knowledge of adverse effects note by any patient post administration. The outcome of temperature excursion and ZOSTAVAX, VARIVAX and PROQUAD all supported post cycling events described were unknown. This case is case 2 of 3. This case is related to case 1405USA001785 and 1405USA004771 (same reporter link). Additional information has been requested.